Work

Abstract PS1-13-15: A new FDA approved docetaxel + albumin formulation for breast cancer treatment

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-13-15

Authors: H. Biswas, D. Desai, Q. Sun

Institutions: Syneos Health (United States), Zydus Pharmaceuticals (United States)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129197157

Cites:

Cited by:

Related to: